AKT1 and malignant glioma: In malignant gliomas, overexpression and constitutive activation of growth factor receptors, such as EGF receptor and IGF-1 receptor, and inactivation of pathway-controlling tumor suppressor genes such as PTEN, lead to overactivation of PI3K-AKT signaling and its downstream signal transduction pathways.